STT vs UTHR · P/E 17, rev $7.84B vs P/E 20, rev $1.56B
State Street Corp (STT) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
State Street Corp (STT) is a asset management company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
STT currently screens at market cap $45.02B and trailing P/E 16.5. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the STT and UTHR stock pages for the full models.
Not investment advice.